Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma

Rui Li; Xiao Liu; Xi-Jia Zhou; Xiao Chen; Xiao Chen; Jian-Ping Li; Yun-Hong Yin; Yi-Qing Qu

doi:10.3389/fonc.2020.01588

Frontiers in Oncology (Sep 2020)

Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma

Rui Li,
Xiao Liu,
Xi-Jia Zhou,
Xiao Chen,
Xiao Chen,
Jian-Ping Li,
Yun-Hong Yin,
Yi-Qing Qu

Affiliations

Rui Li: Department of Pulmonary and Critical Care Medicine, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, China
Xiao Liu: Department of Pulmonary and Critical Care Medicine, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, China
Xi-Jia Zhou: Department of Pulmonary and Critical Care Medicine, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, China
Xiao Chen: Department of Pulmonary and Critical Care Medicine, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, China
Xiao Chen: Department of Respiratory Medicine, Tai'an City Central Hospital, Tai'an, China
Jian-Ping Li: Department of Pulmonary and Critical Care Medicine, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan, China
Yun-Hong Yin: Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China
Yi-Qing Qu: Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China

DOI: https://doi.org/10.3389/fonc.2020.01588
Journal volume & issue: Vol. 10

Abstract

Read online

Immune-related genes (IRGs) play considerable roles in tumor immune microenvironment (IME). This research aimed to discover the differentially expressed immune-related genes (DEIRGs) based on the Cox predictive model to predict survival for lung squamous cell carcinoma (LUSC) through bioinformatics analysis. First of all, the differentially expressed genes (DEGs) were acquired based on The Cancer Genome Atlas (TCGA) using the limma R package, the DEIRGs were obtained from the ImmPort database, whereas the differentially expressed transcription factors (DETFs) were acquired from the Cistrome database. Thereafter, a TFs-mediated IRGs network was constructed to identify the candidate mechanisms for those DEIRGs in LUSC at molecular level. Moreover, Gene Ontology (GO), together with Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, was conducted for exploring those functional enrichments for DEIRGs. Besides, univariate as well as multivariate Cox regression analysis was conducted for establishing a prediction model for DEIRGs biomarkers. In addition, the relationship between the prognostic model and immunocytes was further explored through immunocyte correlation analysis. In total, 3,599 DEGs, 223 DEIRGs, and 46 DETFs were obtained from LUSC tissues and adjacent non-carcinoma tissues. According to multivariate Cox regression analysis, 10 DEIRGs (including CALCB, GCGR, HTR3A, AMH, VGF, SEMA3B, NRTN, ENG, ACVRL1, and NR4A1) were retrieved to establish a prognostic model for LUSC. Immunocyte infiltration analysis showed that dendritic cells and neutrophils were positively correlated with IRGs, which possibly exerted an important part within the IME of LUSC. Our study identifies a prognostic model based on IRGs, which is then used to predict LUSC prognosis and analyze immunocyte infiltration. This may provide a novel insight for exploring the potential IRGs in the IME of LUSC.

Published in Frontiers in Oncology

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/

About the journal

Abstract

Keywords